<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0376331</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5212</journal-id>
<journal-id journal-id-type="nlm-ta">J Psychiatr Res</journal-id>
<journal-id journal-id-type="iso-abbrev">J Psychiatr Res</journal-id>
<journal-title-group>
<journal-title>Journal of psychiatric research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3956</issn>
<issn pub-type="epub">1879-1379</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29407287</article-id>
<article-id pub-id-type="pmc">5849533</article-id>
<article-id pub-id-type="doi">10.1016/j.jpsychires.2018.01.013</article-id>
<article-id pub-id-type="manuscript">NIHMS939097</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Overview and Systematic Review of Studies of Microbiome in Schizophrenia and Bipolar Disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nguyen</surname>
<given-names>Tanya T.</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kosciolek</surname>
<given-names>Tomasz</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eyler</surname>
<given-names>Lisa T.</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Knight</surname>
<given-names>Rob</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jeste</surname>
<given-names>Dilip V.</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>VA San Diego Healthcare System, Mental Illness Research, Education, and Clinical Center (MIRECC), San Diego, California</aff>
<aff id="A2">
<label>2</label>Department of Psychiatry, University of California San Diego, California</aff>
<aff id="A3">
<label>3</label>Department of Pediatrics, University of California San Diego, California</aff>
<aff id="A4">
<label>4</label>Center for Microbiome Innovation, University of California San Diego, California</aff>
<aff id="A5">
<label>5</label>Department of Computer Science and Engineering, University of California San Diego, California</aff>
<aff id="A6">
<label>6</label>Department of Neurosciences, University of California San Diego, California</aff>
<aff id="A7">
<label>7</label>Sam and Rose Stein Institute for Research on Aging, University of California San Diego, California</aff>
<author-notes>
<corresp id="FN1"><bold>Correspondence should be addressed to:</bold> Dilip V. Jeste, M.D., Senior Associate Dean for Healthy Aging and Senior Care, Distinguished Professor of Psychiatry and Neurosciences, Director, Sam and Rose Stein Institute for Research on Aging, University of California San Diego, 9500 Gilman Drive #0664, La Jolla, CA 92093, Phone: (858)-534-4020, Fax: (858)-543-5475, <email>djeste@ucsd.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p>
<bold>CONFLICT OF INTEREST</bold>
</p>
<p>The authors have declared that there are no conflicts of interest in relation to the subject of this study.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>2</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>4</month>
<year>2019</year>
</pub-date>
<volume>99</volume>
<fpage>50</fpage>
<lpage>61</lpage>
<!--elocation-id from pubmed: 10.1016/j.jpsychires.2018.01.013-->
<abstract>
<p id="P1">Schizophrenia and bipolar disorder are among the leading causes of disability, morbidity, and mortality worldwide. In addition to being serious mental illness, these disorders are associated with considerable systemic physiological dysfunction, including chronic inflammation and elevated oxidative stress. The advent of sophisticated sequencing techniques has led to a growing interest in the potential role of gut microbiota in human health and disease. Advances in this area have transformed our understanding of a number of medical conditions and have generated a new perspective suggesting that gut microbiota might be involved in the development and maintenance of brain / mental health. Animal models have demonstrated strong though indirect evidence for a contributory role of intestinal microbiota in psychiatric symptomatology and have linked the microbiome with neuropsychiatric conditions. We present a systematic review of clinical studies of microbiome in schizophrenia and bipolar disorder. The published literature has a number of limitations; however, the investigations suggest that these disorders are associated with reduced microbial diversity and show global community differences compared to non-psychiatric comparison samples. In some reports, specific microbial taxa were associated with clinical disease characteristics, including physical health, depressive and psychotic symptoms, and sleep, but little information on the functional potential of those community changes. Studies also suggest increased intestinal inflammation and permeability, which may be among principal mechanism by which microbial dysbiosis impacts systemic physiological functioning. We highlight gaps in the current literature and implications for diagnosis and therapeutic interventions, and outline future directions for microbiome research in psychiatry.</p>
</abstract>
<kwd-group>
<kwd>Psychosis</kwd>
<kwd>depression</kwd>
<kwd>gut</kwd>
<kwd>bacteria</kwd>
<kwd>microbes</kwd>
<kwd>inflammation</kwd>
<kwd>oxidative stress</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>